Clinical Trial Update: The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

View source ↗

Summary

This update reports on the incidence of ESBL-producing Klebsiella pneumoniae in patients with end-stage renal disease undergoing renal replacement therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Inje University | Conditions: End-stage Renal Disease | Status: COMPLETED